Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Mersana Therapeutics, Inc. Financials Banner

Mersana Therapeutics, Inc. Financials

MRSN Stock Analysis

Page title

Section title

MRSN Income Statement Key Metrics

  • Revenue(TTM)29.94 M
  • Gross Profit(TTM)28.24 M
  • EBITDA(TTM)-106.98 M
  • Net Income(TTM)-104.77 M
  • EPS Diluted(TTM)-0.87

Decode MRSN's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

MRSN earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of MRSN (0.959) is higher than the average of its peers (-0.038).

Net Profit Margin vs Peers

Net profit margin ratio of MRSN (-4.658) is higher than the average of its peers (-48.510).

MRSN Return on Equity

See how efficiently MRSN generates profit for it's shareholders.

-465.18%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of MRSN (-4.652) is lower than the average of its peers (-0.505).

Return on Equity Growth

MRSN's Return on Equity has shown poor growth over the past 10 years, increasing by only -31.91%.

MRSN Revenue Growth

See how MRSN has grown it's revenue over the past 10 years.


Revenue Growth

MRSN's revenue has grown significantly over the past 10 years, increasing by over 15.14%.

MRSN FY, 2023 Revenue Breakdown

See how MRSN converts it's revenue into profit.

MRSN Balance Sheet Health

MRSN Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

MRSN financial position analysis

Short Term Liabilities

MRSN's short term assets($214M) can safely cover it's short term liabilities($64M).

Long Term Liabilities

MRSN's short term assets($214M) can safely cover it's long term liabilities($126M).

MRSN Debt to Equity